REQUEST A DEMO
Total
USD $0.00
Search more companies

Surge Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Surge Pharmaceuticals Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Surge Pharmaceuticals Private Limited is an unlisted company, incorporated on 11/09/2007. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24239GJ2007PTC051709 and registration number is 051709. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Sb-28/A, Arpan Complex, Nizampura
Vadodara; Gujarat; Postal Code: 390002

Contact Details: Purchase the Surge Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Surge Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Surge Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Surge Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
September 11, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Surge Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
10.68%
Total operating revenue
12.17%
Operating profit (EBIT)
-64.91%
EBITDA
-15.76%
Net Profit (Loss) for the Period
-63.55%
Total assets
13.97%
Total equity
1.53%
Operating Profit Margin (ROS)
-0.51%
Net Profit Margin
-0.35%
Return on Equity (ROE)
-2.69%
Debt to Equity Ratio
-48.35%
Quick Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?